Nature's Sunshine Products, Inc.
General ticker "NATR" information:
- Sector: Consumer Staples
- Industry: Personal Care Products
- Capitalization: $271.1M (TTM average)
Nature's Sunshine Products, Inc. follows the US Stock Market performance with the rate: 40.6%.
Estimated limits based on current volatility of 1.3%: low 20.70$, high 21.24$
Factors to consider:
- Total employees count: 819 (+0.6%) as of 2024
- US accounted for 28.2% of revenue in the fiscal year ended 2024-12-31
- Top business risk factors: Geopolitical risks, War in ukraine, Pandemic risks, Supply chain disruptions, Regulatory and compliance
- Earnings for 9 months up through Q3 exceed our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2024-12-31 to 2026-12-31
- 2024-12-31 to 2025-12-31 estimated range: [14.39$, 21.82$]
- 2025-12-31 to 2026-12-31 estimated range: [15.54$, 23.61$]
Financial Metrics affecting the NATR estimates:
- Positive: with PPE of 37.5 at the end of fiscal year the price was very low
- Positive: -3.60 < Operating profit margin, % of 4.42
- Negative: Shareholder equity ratio, % of 66.84 > 63.39
- Negative: Industry operating cash flow per share per price (median), % of 4.60 <= 5.52
- Negative: Industry earnings per price (median), % of 0 <= 0
- Positive: 6.82 < Operating cash flow per share per price, % of 9.06
- Negative: 0.01 < Interest expense per share per price, % of 0.05
- Positive: -4.48 < Investing cash flow per share per price, % of -3.93
- Negative: Industry inventory ratio change (median), % of 1.85 > 0.28
Short-term NATR quotes
Long-term NATR plot with estimates
Financial data
| YTD | 2022-12-31 | 2023-12-31 | 2024-12-31 |
|---|---|---|---|
| Operating Revenue | $421.91MM | $445.32MM | $454.36MM |
| Operating Expenses | $405.65MM | $426.57MM | $434.27MM |
| Operating Income | $16.26MM | $18.75MM | $20.09MM |
| Non-Operating Income | $-1.04MM | $1.45MM | $-1.67MM |
| Interest Expense | $0.25MM | $0.07MM | $0.15MM |
| R&D Expense | $1.50MM | $0.00MM | $1.70MM |
| Income(Loss) | $15.21MM | $20.20MM | $18.43MM |
| Taxes | $14.66MM | $3.79MM | $10.53MM |
| Profit(Loss)* | $-0.39MM | $15.08MM | $7.70MM |
| Stockholders Equity | $147.05MM | $159.54MM | $160.99MM |
| Inventory | $67.95MM | $66.89MM | $59.44MM |
| Assets | $229.78MM | $249.77MM | $240.85MM |
| Operating Cash Flow | $0.71MM | $41.23MM | $25.30MM |
| Capital expenditure | $7.63MM | $10.48MM | $10.97MM |
| Investing Cash Flow | $-7.63MM | $-10.48MM | $-10.97MM |
| Financing Cash Flow | $-16.25MM | $-7.96MM | $-9.90MM |
| Earnings Per Share** | $-0.02 | $0.79 | $0.41 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.